Current perspectives on the design of phase II trials of new drugs for the treatment of heart failure

Am Heart J. 2000 Apr;139(4):S202-6. doi: 10.1016/s0002-8703(00)90074-7.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Cardiotonic Agents / adverse effects
  • Cardiotonic Agents / therapeutic use*
  • Clinical Trials, Phase II as Topic / statistics & numerical data*
  • Drug Design
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / therapeutic use*
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Pilot Projects
  • Research Design
  • Survival Analysis
  • Treatment Outcome

Substances

  • Cardiotonic Agents
  • Drugs, Investigational